Research News

Latest Advances in Lung Cancer Research

Explore our curated selection of the latest breakthroughs in lung cancer research.

Clear Filter
  • August 19, 2021

    Liquid Biopsy Simpler Sampling

    Liquid biopsy simpler sampling: Liquid biopsies are easier on patients, yield faster results and cost less than tissue biopsies.

    Lung Cancer Info Testing
  • August 19, 2021

    Address Disparities in Lung Cancer Screening

    Address disparities in lung cancer screening. Abstracts presented at ASCO’s 2021 annual meeting address disparities in lung cancer screening.

    ASCO Daily News

  • August 18, 2021

    Future of Liquid Biopsy

    Future of liquid biopsy: Analysis of tumours using biomarkers in blood is beginning to transform cancer diagnosis.


    Diagnosis Lung Cancer Info Testing
  • July 1, 2021

    Lower Risk of Brain Mets

    Lower risk of brain mets from screening. LDCT Screening linked to lower risk of brain mets for lung cancer patients.

    MEDPAGE Today

  • July 1, 2021

    Imfinzi increases five year survival to 43%

    Imfinzi increases five year survival to 43% in patients with Stage III non-small cell lung cancer. After treatment, 43% survive 5+ years.

    European Pharmaceutical Review

  • June 25, 2021

    Role of Postoperative Radiotherapy in NSCLC

    Dr. Karen Marrone discusses the role of postoperative radiotherapy (PORT) in early-stages of non-small cell lung cancer (NSCLC).


    Lung Cancer Info Treatment
  • June 25, 2021

    Diverse Workforce in Oncology

    Diverse workforce in oncology: Improvement of inclusion and equity critical to reducing health disparities in cancer care.

    ASCO Daily News

    Investigators Research
  • June 15, 2021

    New NSCLC Targeted Therapy Guidelines

    New NSCLC targeted therapy guidelines have been published. They are updates to the 2017 systemic therapy recommendations.

    The ASCO Post

    Targeted Therapy

Get the latest lung cancer research news directly in your inbox.

Learn more about:

  • the latest science in lung cancer
  • stories about living with lung cancer
  • how LCFA is working to fund more lung cancer research grants

LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers.